Autonomize AI, an Austin, TX-based firm which speicializes in AI-driven healthcare options, raised $28M in Sequence A funding.
The spherical was led by Valtruis, The Cigna Group Ventures, Tau Ventures, and different strategic buyers. Asset Administration Ventures, ATX Enterprise Companions and Capital Manufacturing unit additionally participated.
The corporate intends to make use of the funds to speed up its enlargement and improvement efforts
Based in 2022 by Ganesh Padmanabhan and Kris Nair, Autonomize AI affords copilot companies that manage, contextualize and summarize unstructured knowledge to scale back the executive burden for healthcare information staff to make data-driven selections and enhance affected person outcomes. Their clients embody Prime 20 Prescription drugs, Fortune 100 Healthcare Enterprises, and Life Sciences firms.
It has already achieved transformative outcomes, together with:
- 36,000 scientific hours saved monthly that was spent on mundane administrative duties;
- 100,000+ automated care plans created month-to-month to unlock care suppliers and case managers for affected person interactions; and
- As much as 50% quicker selections for sufferers in prior authorizations and claims.
The increase introduced the overall quantity to $32M.
FinSMEs
13/06/2025
